Cargando…

N-acetylcysteine for Prevention of Contrast-Induced Nephropathy: A Narrative Review

Contrast-induced nephropathy (CIN) affects in-hospital, short- and long-term morbidity and mortality. It also leads to prolonged hospital stay and increased medical cost. Given the potential clinical severity of CIN, there has been considerable interest in the development of preventative strategies...

Descripción completa

Detalles Bibliográficos
Autor principal:	Jo, Sang-Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Cardiology 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3257451/ https://www.ncbi.nlm.nih.gov/pubmed/22259598 http://dx.doi.org/10.4070/kcj.2011.41.12.695

Ejemplares similares

Evaluation of N-acetylcysteine for the prevention of contrast-induced nephropathy
por: Richter, Sara K., et al.
Publicado: (2015)

Comparison between theophylline, N-acetylcysteine, and theophylline plus N-acetylcysteine for the prevention of contrast-induced nephropathy
por: Arabmomeni, Morteza, et al.
Publicado: (2015)

Comparison of N-acetylcysteine, ascorbic acid, and normal saline effect in prevention of contrast-induced nephropathy
por: Khaledifar, Arsalan, et al.
Publicado: (2015)

Intravenous N-Acetylcysteine for Prevention of Contrast-Induced Nephropathy: A Meta-Analysis of Randomized, Controlled Trials
por: Sun, Zikai, et al.
Publicado: (2013)

N-Acetylcysteine: more than preventing contrast-induced nephropathy in uremic patients—focus on the antioxidant and anti-inflammatory properties
por: Cepaityte, Dainora, et al.
Publicado: (2023)

Evaluation of the protective effect of N-acetylcysteine on contrast media nephropathy
por: Pezeshgi, Aiyoub, et al.
Publicado: (2015)

Effectiveness of N‐Acetylcysteine for the Prevention of Contrast‐Induced Nephropathy: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
por: Xu, Renfan, et al.
Publicado: (2016)

Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy
Publicado: (2009)

Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: A systematic review and meta-analysis
por: Bagshaw, Sean M, et al.
Publicado: (2004)

Association of N-acetylcysteine use with contrast-induced nephropathy: an umbrella review of meta-analyses of randomized clinical trials
por: Zhu, Rong, et al.
Publicado: (2023)

Intravenous N-acetylcysteine for the PRevention Of Contrast-induced nephropathy – a prospective, single-center, randomized, placebo-controlled trial. The INPROC trial
por: Biernacka-Fiałkowska, Barbara, et al.
Publicado: (2018)

N-acetylcysteine does not prevent contrast nephropathy in patients with renal impairment undergoing emergency CT: a randomized study
por: Poletti, Pierre-Alexandre, et al.
Publicado: (2013)

Oral N-acetylcysteine for prophylaxis of contrast-induced nephropathy in patients following coronary angioplasty: A meta-analysis
por: Li, Jing-Xiu, et al.
Publicado: (2017)

Expression of neutrophil gelatinase-associated lipocalin in low osmolar contrast-induced nephropathy in rats and the effect of N-acetylcysteine
por: Li, Wen-Hua, et al.
Publicado: (2016)

Prophylaxis of contrast-induced nephropathy in patients with impaired renal function: double-blind comparison of acetylcysteine, theophylline, acetylcysteine + theophylline and placebo
por: Huber, W, et al.
Publicado: (2005)

Contrast-induced nephropathy: pharmacology, pathophysiology and prevention
por: Geenen, Remy W. F., et al.
Publicado: (2013)

N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial
por: Amini, Manouchehr, et al.
Publicado: (2009)

Dose escalation study of intravenous and intra-arterial N-acetylcysteine for the prevention of oto- and nephrotoxicity of cisplatin with a contrast-induced nephropathy model in patients with renal insufficiency
por: Dósa, Edit, et al.
Publicado: (2017)

The impact of N-acetylcysteine and ascorbic acid in contrast-induced nephropathy in critical care patients: an open-label randomized controlled study
por: Palli, Eleni, et al.
Publicado: (2017)

Acetylcysteine has No Mechanistic Effect in Patients at Risk of Contrast‐Induced Nephropathy: A Failure of Academic Clinical Science
por: Sandilands, Euan A., et al.
Publicado: (2022)

N-acetylcysteine ameliorates contrast-induced kidney injury in rats with unilateral hydronephrosis
por: Xia, Qiang, et al.
Publicado: (2018)

N-Acetylcysteine for Preventing Acetaminophen-Induced Liver Injury: A Comprehensive Review
por: Licata, Anna, et al.
Publicado: (2022)

Contrast-induced Nephropathy
por: Mohammed, Nazar M. A., et al.
Publicado: (2013)

Bench-to-bedside review: Preventive measures for contrast-induced nephropathy in critically ill patients
por: van den Berk, Guido, et al.
Publicado: (2005)

Contrast safety in the cancer patient: preventing contrast-induced nephropathy
por: Heiken, Jay P.
Publicado: (2008)

Endogenous and Exogenous Antioxidants as Agents Preventing the Negative Effects of Contrast Media (Contrast-Induced Nephropathy)
por: Panova, Ina G., et al.
Publicado: (2023)

Contrast induced nephropathy in urology
por: Thomson, Viji Samuel, et al.
Publicado: (2009)

N-Acetylcysteine to Combat COVID-19: An Evidence Review
por: Shi, Zhongcheng, et al.
Publicado: (2020)

A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity
por: Gonzales, Denise A, et al.
Publicado: (2007)

N-acetylcysteine modulates lipopolysaccharide-induced intestinal dysfunction
por: Lee, Sang In, et al.
Publicado: (2019)

Evaluation of Short-Term Use of N-Acetylcysteine as a Strategy for Prevention of Anthracycline-Induced Cardiomyopathy: EPOCH Trial - A Prospective Randomized Study
por: Jo, Sang-Ho, et al.
Publicado: (2013)

N-acetylcysteine for non-acetaminophen induced acute liver failure: A review
por: Jiang, Shirley Xue, et al.
Publicado: (2022)

Contrast-induced nephropathy in interventional cardiology
por: Sudarsky, Doron, et al.
Publicado: (2011)

N-Acetylcysteine prevents congenital heart defects induced by pregestational diabetes
por: Moazzen, Hoda, et al.
Publicado: (2014)

Ultra-low contrast coronary angiography and zero-contrast percutaneous coronary intervention for prevention of contrast-induced nephropathy: step-by-step approach and review
por: Sacha, Jerzy, et al.
Publicado: (2019)

Role of N-acetylcysteine in the management of COPD
por: Sadowska, Anna M, et al.
Publicado: (2006)

The role for N-acetylcysteine in the management of COPD
por: Dekhuijzen, PNR, et al.
Publicado: (2006)

Medical and Dietary Uses of N-Acetylcysteine
por: Šalamon, Špela, et al.
Publicado: (2019)

Virus-Associated Nephropathies: A Narrative Review
por: Masset, Christophe, et al.
Publicado: (2022)

Contrast-induced nephropathy – a review of current literature and guidelines
por: Maliborski, Artur, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_rbj3b9lj68hh4a8tvb1g3kkqd4